medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2012, Number 1

<< Back Next >>

Rev Invest Clin 2012; 64 (1)

Effect of an educative intervention on the clinical ability of physicians in the management of metabolic syndrome

Cabrera-Pivaral CE, Anaya-Prado R, González-Pérez G, Vega-López MG, Centeno-López NM

Language: Spanish
References: 20
Page: 74-80
PDF size: 133.77 Kb.


ABSTRACT

Purpose. To measure the effect of an educative intervention on the clinical ability of Family Physicians of two Family Units of the Mexican Institute of Social Security (IMSS) in the diagnosis and treatment of patients with metabolic syndrome. Material and methods. A quasi-experimental study was conducted with a control group using basal and final measurements. The educative intervention of the experiment group included one in-the-classroom work and another at the doctors’ office. The instrument was validated by a panel of experts and included 140 items and five case-oriented problems, reaching a reliability index of 0.87. Results. There was no significant difference at base measurement among the different levels of clinical ability between the two groups (p = 0.82), both the experimental and the control groups showed a higher frequency of medium level abilities (33.3 vs. 36.8% respectively). At the end of the follow-up, a significant increase in the experimental group (98 with 49-106 over 69 with 26-94) was observed. Conclusions. The educative intervention utilized in this study improved the ability of Family Physicians to diagnose, treat an apply preventive measures in patients with metabolic syndrome.


REFERENCES

  1. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The Metabolic Syndrome: A global public health problem and a new definition. J Atheroscler Thromb 2005; 12: 295-300.

  2. Córdoba-Villalobos JA, Burguete-Meléndez JA, Lara-Esqueda A, Barquera S, Rosas-Peralta M, Hernández-Ávila M, et al. Las enfermedades crónicas no transmisibles en México: sinopsis epidemiológica y prevención integral. Sal Pub Mex 2008; 50(5): 419-27.

  3. González CA, Sánchez ZM, Elizondo AS, Malanco HL. Inflamación y resistencia a la insulina, su papel en el desarrollo del síndrome metabólico. En: Annual Review del Colegio de Medicina Interna de México. 1a. Ed. México: Editorial Intersistemas; 2005.

  4. Luquez H, De Loredo L, Madoery RJ. Síndrome metabólico: prevalencia en dos comunidades de Córdoba Argentina de acuerdo con definiciones de ATPIII y OMS. Ref Fed Arg Cardiol 2005; (34): 80-95.

  5. Rodríguez PA, Sánchez LM, Martínez VL. Síndrome metabólico. Rev Cub Endocrinol 2002; 13(3): 238-52.

  6. Dekker JM, Girmain C, Rhodes T, Nipjels G. Metabolic Syndrome and 10 year cardiovascular disease risk in the Hoorn study. Circulation 2005; 112: 666-73.

  7. Sabido SMC, Viniegra VL. Competencia y desempeño en la evaluación del médico: estudio con pacientes diabéticos en el primer nivel de atención. En: Viniegra VL. La investigación en la educación. Papel de la teoría y de la observación. 1a. Ed. México: IMSS; 2000: 251-70.

  8. Kenneth E, Heikes, David M, Hedy. Diabetes risk calculator. A simple tool for detecting undiagnosed diabetes and pre-diabetes. Diabetes Care 2008; 31(5): 1040-4.

  9. American Diabetes Association. Standards of Medical Care in Diabetes-2010. Diabetes Care 2010; 33(1): S11-S61.

  10. Burr WA. Diabetes UK. Diabet Med 2004; 21: 1-16.

  11. Viniegra VL, JL Pérez-Padilla JR. El desafío de la evaluación de la competencia clínica. Rev Med IMSS 1991; (43): 87-95.

  12. Wikström K, Peltonen M, Eriksson JG, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, et al. Educational attainment and effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diab Res Clin Pract 2009; 86(1).

  13. Deen D. Metabolic syndrome: Time for action: Time for action. Am Fam Physicians 2004: 69: 2875-82.

  14. Lindström J, Peltonen M, Eriksson JG, Aunola S, Hämäläinen H, Ilanne-Parikka P, et al. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care 2008; 31(5): 857-62.

  15. Grupo de Estudio del Síndrome Metabólico. Consenso Mexicano sobre el Tratamiento Integral del Síndrome Metabólico. Rev Mex Cardiol 2002; 13(1): 4-30.

  16. Secretaría de Salud. Reglamento de la Ley General de Salud en materia de investigación para la salud. México, D.F.: SSA; 1990.

  17. Searle J. Defining competency-the role of standard setting. Med Educ 2000; (34): 363-6.

  18. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368(9548): 1673-9.

  19. Aráuz AG, Sánchez G, Padilla G, Fernández M, Rosello M, Guzmán S. Intervención educativa comunitaria sobre la diabetes en el ámbito de la atención primaria. Rev Panam Salud 2001; 9(3): 145-53.

  20. Flores H. Traducción del conocimiento de factores de riesgo en intervenciones prácticas a nivel poblacional. Sal Pub Mex 2007; 49: E308-E310.




2020     |     www.medigraphic.com